069620 — Daewoong Pharma Share Price

As of Today at 19:06 UTC, shares in Daewoong Pharma are trading at KR₩112,200. This share price information is delayed by 15 minutes.

Shares in Daewoong Pharma last closed at KR₩112,200 and the price had moved by -1.84% over the past 365 days. In terms of relative price strength the Daewoong Pharma share price has underperformed the FTSE Developed Asia Pacific Index by -2.6% over the past year.

The overall consensus recommendation for Daewoong Pharma is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.

The Daewoong Pharma dividend yield is 0.53% based on the trailing twelve month period.

Last year, Daewoong Pharma paid a total dividend of KR₩600, and it currently has a trailing dividend yield of 0.53%. We do not have any data on when Daewoong Pharma is to next pay dividends.

We do not have data on when Daewoong Pharma is to next pay dividends.  The historic dividend yield on Daewoong Pharma shares is currently 0.53%.

To buy shares in Daewoong Pharma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

As of the previous close price of KR₩112,200, shares in Daewoong Pharma had a market capitalisation of KR₩1tn.

Here are the trading details for Daewoong Pharma: 

• Country of listing: Korea, Republic of
• Exchange: KSC
• Ticker Symbol: 069620

Based on an overall assessment of its quality, value and momentum Daewoong Pharma is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

The analyst consensus target price for shares in Daewoong Pharma is KR₩165,000.  That is 47.06% above the last closing price of KR₩112,200.

Analysts covering Daewoong Pharma currently have a consensus Earnings Per Share (EPS) forecast of KR₩8,045 for the next financial year.

An important predictor of whether a stock price will go up is its track record of momentum.  Price trends tend to persist, so it's worth looking at them when it comes to a share like Daewoong Pharma. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +5.48%.

As of the last closing price of KR₩112,200, shares in Daewoong Pharma were trading +2.2% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

The Daewoong Pharma PE ratio based on its reported earnings over the past 12 months is 12.86. The shares last closed at KR₩112,200. 

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Daewoong Pharma's management team is headed by: 

• Yeong Hwan Yoon - CHM
• Jong Wuk Lee - CCE
• Jae Hun Yoon - CCE
• Jae Seung Yoon - VCH
• Jae Hong Park - MDR
• Seung Ho Baek - MDR
• Hye Suk Jeon - MDR
• Ho Gyeong Lee - MDR
• Won Geun Lee - MDR
• Gap Yong Noh - OTH
• Su Jin Choi - OTH
• Ho Jeong Jin - OTH
• Beom Su Kim - OTH
• Byeong Wu Kim - OTH
• Seung Han Lee - OTH
• Yong Su Lee - OTH
• Gyeong Yong Park - OTH
• Jin Hwan Park - OTH
• Jong Won Seo - OTH
• Jun Pyo Hong - NID
• Jae Saeng Sung - NID